Literature DB >> 27992625

Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients.

Andres Rodriguez Ruiz1, Jan Vlachy2, Jong Woo Lee3, Emily J Gilmore4, Turgay Ayer2, Hiba Arif Haider1, Nicolas Gaspard5, J Andrew Ehrenberg1, Benjamin Tolchin3, Tadeu A Fantaneanu3, Andres Fernandez6, Lawrence J Hirsch4, Suzette LaRoche7.   

Abstract

IMPORTANCE: Periodic and rhythmic electroencephalographic patterns have been associated with risk of seizures in critically ill patients. However, specific features that confer higher seizure risk remain unclear.
OBJECTIVE: To analyze the association of distinct characteristics of periodic and rhythmic patterns with seizures. DESIGN, SETTING, AND PARTICIPANTS: We reviewed electroencephalographic recordings from 4772 critically ill adults in 3 academic medical centers from February 2013 to September 2015 and performed a multivariate analysis to determine features associated with seizures.
INTERVENTIONS: Continuous electroencephalography. MAIN OUTCOMES AND MEASURES: Association of periodic and rhythmic patterns and specific characteristics, such as pattern frequency (hertz), Plus modifier, prevalence, and stimulation-induced patterns, and the risk for seizures.
RESULTS: Of the 4772 patients included in our study, 2868 were men and 1904 were women. Lateralized periodic discharges (LPDs) had the highest association with seizures regardless of frequency and the association was greater when the Plus modifier was present (58%; odds ratio [OR], 2.00, P < .001). Generalized periodic discharges (GPDs) and lateralized rhythmic delta activity (LRDA) were associated with seizures in a frequency-dependent manner (1.5-2 Hz: GPDs, 24%,OR, 2.31, P = .02; LRDA, 24%, OR, 1.79, P = .05; ≥ 2 Hz: GPDs, 32%, OR, 3.30, P < .001; LRDA, 40%, OR, 3.98, P < .001) as was the association with Plus (GPDs, 28%, OR, 3.57, P < .001; LRDA, 40%, P < .001). There was no difference in seizure incidence in patients with generalized rhythmic delta activity compared with no periodic or rhythmic pattern (13%, OR, 1.18, P = .26). Higher prevalence of LPDs and GPDs also conferred increased seizure risk (37% frequent vs 45% abundant/continuous, OR, 1.64, P = .03 for difference; 8% rare/occasional vs 15% frequent, OR, 2.71, P = .03, vs 23% abundant/continuous, OR, 1.95, P = .04). Patterns associated with stimulation did not show an additional risk for seizures from the underlying pattern risk (P > .10). CONCLUSIONS AND RELEVANCE: In this study, LPDs, LRDA, and GPDs were associated with seizures while generalized rhythmic delta activity was not. Lateralized periodic discharges were associated with seizures at all frequencies with and without Plus modifier, but LRDA and GPDs were associated with seizures when the frequency was 1.5 Hz or faster or when associated with a Plus modifier. Increased pattern prevalence was associated with increased risk for seizures in LPDs and GPDs. Stimulus-induced patterns were not associated with such risk. These findings highlight the importance of detailed electroencephalographic interpretation using standardized nomenclature for seizure risk stratification and clinical decision making.

Entities:  

Mesh:

Year:  2017        PMID: 27992625     DOI: 10.1001/jamaneurol.2016.4990

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  55 in total

1.  Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures.

Authors:  Aatif M Husain; Jong W Lee; Bradley J Kolls; Lawrence J Hirsch; Jonathan J Halford; Puneet K Gupta; Yafa Minazad; Jennifer M Jones; Suzette M LaRoche; Susan T Herman; Christa B Swisher; Saurabh R Sinha; Adriana Palade; Keith E Dombrowski; William B Gallentine; Cecil D Hahn; Elizabeth E Gerard; Manjushri Bhapkar; Yuliya Lokhnygina; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-06       Impact factor: 10.422

2.  Continuous Electroencephalography After Moderate to Severe Traumatic Brain Injury.

Authors:  Hyunjo Lee; Moshe A Mizrahi; Jed A Hartings; Sameer Sharma; Laura Pahren; Laura B Ngwenya; Brian D Moseley; Michael Privitera; Frank C Tortella; Brandon Foreman
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

Review 3.  Electroencephalographic Patterns in Neurocritical Care: Pathologic Contributors or Epiphenomena?

Authors:  Brian Appavu; James J Riviello
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

4.  It HELPS 2NO When to Stop Continuous EEG Monitoring in Critically Ill Patients.

Authors:  Aatif M Husain
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

Review 5.  The Ictal-Interictal Continuum: To Treat or Not to Treat (and How)?

Authors:  Clio Rubinos; Alexandra S Reynolds; Jan Claassen
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

6.  Predicting a Storm by Watching the Waves.

Authors:  Edward Faught
Journal:  Epilepsy Curr       Date:  2018 Mar-Apr       Impact factor: 7.500

7.  Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction.

Authors:  Aaron F Struck; Mohammad Tabaeizadeh; Sarah E Schmitt; Andres Rodriguez Ruiz; Christa B Swisher; Thanujaa Subramaniam; Christian Hernandez; Safa Kaleem; Hiba A Haider; Abbas Fodé Cissé; Monica B Dhakar; Lawrence J Hirsch; Eric S Rosenthal; Sahar F Zafar; Nicholas Gaspard; M Brandon Westover
Journal:  JAMA Neurol       Date:  2020-04-01       Impact factor: 18.302

8.  Epileptiform activity in traumatic brain injury predicts post-traumatic epilepsy.

Authors:  Jennifer A Kim; Emily J Boyle; Alexander C Wu; Andrew J Cole; Kevin J Staley; Sahar Zafar; Sydney S Cash; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

9.  Defining the latent period of epileptogenesis and epileptogenic zone in a focal cortical dysplasia type II (FCDII) rat model.

Authors:  Hsin-Yi Kao; Shuntong Hu; Temenuzhka Mihaylova; Julie Ziobro; EunSeon Ahn; Carli Fine; David Brang; Brendon O Watson; Yu Wang
Journal:  Epilepsia       Date:  2021-03-18       Impact factor: 5.864

Review 10.  Pharmacotherapy for Nonconvulsive Seizures and Nonconvulsive Status Epilepticus.

Authors:  Pablo Bravo; Aparna Vaddiparti; Lawrence J Hirsch
Journal:  Drugs       Date:  2021-04-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.